What is the new oral medication they are giving MS (Multiple Sclerosis) patients?
Question:
Answers:
FTY720 is a new, once-daily oral medication currently in Phase II trials.
"FTY720 has shown a significant and consistent effect on both clinical relapses and MRI measures in just six months. With its novel mode of action and the added benefit of an oral formulation taken once daily, further clinical development of FTY720 might have a major impact on the way we treat MS in the future. We hope that the magnitude of benefits shown in phase II will be confirmed in the larger scale phase III study program," said Professor Ludwig Kappos, MD, Department of Neurology, University Hospital, Basel, Switzerland.
HTH
Wow , wouldnt it be nice to have an oral med someday?? I sure get tired of being a pin cushion.
Novartis Pharmaceuticals Corporation is conducting the research to find out if investigational drug called FTY720 (Fingolimod) is safe and is beneficial in people who have Multiple Sclerosis (MS).
More Questions & Answers...